Jourdan Michel, Robert Nicolas, Cren Maïlys, Thibaut Coraline, Duperray Christophe, Kassambara Alboukadel, Cogné Michel, Tarte Karin, Klein Bernard, Moreaux Jérôme
Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France.
CHU Montpellier, Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Montpellier, France.
PLoS One. 2017 Jun 21;12(6):e0179793. doi: 10.1371/journal.pone.0179793. eCollection 2017.
FCRL4 is an immunoregulatory receptor that belongs to the Fc receptor-like (FCRL) family. In healthy individuals, FCRL4 is specifically expressed by memory B cells (MBCs) localized in sub-epithelial regions of lymphoid tissues. Expansion of FCRL4+ B cells has been observed in blood and other tissues in various infectious and autoimmune disorders. Currently, the mechanisms involved in pathological FCRL4+ B cell generation are actively studied, but they remain elusive. As in vivo FCRL4+ cells are difficult to access and to isolate, here we developed a culture system to generate in vitro FCRL4+ B cells from purified MBCs upon stimulation with soluble CD40 ligand and/or CpG DNA to mimic T-cell dependent and/or T-cell independent activation, respectively. After 4 days of stimulation, FCRL4+ B cells represented 17% of all generated cells. Transcriptomic and phenotypic analyses of in vitro generated FCRL4+ cells demonstrated that they were closely related to FCRL4+ tonsillar MBCs. They strongly expressed inhibitory receptor genes, as observed in exhausted FCRL4+ MBCs from blood samples of HIV-infected individuals with high viremia. In agreement, cell cycle genes were significantly downregulated and the number of cell divisions was two-fold lower in in vitro generated FCRL4+ than FCRL4- cells. Finally, due to their reduced proliferation and differentiation potential, FCRL4+ cells were less prone to differentiate into plasma cells, differently from FCRL4- cells. Our in vitro model could be of major interest for studying the biology of normal and pathological FCRL4+ cells.
FCRL4是一种免疫调节受体,属于Fc受体样(FCRL)家族。在健康个体中,FCRL4由位于淋巴组织上皮下区域的记忆B细胞(MBC)特异性表达。在各种感染性和自身免疫性疾病的血液和其他组织中,已观察到FCRL4+B细胞的扩增。目前,正在积极研究病理性FCRL4+B细胞产生所涉及的机制,但这些机制仍不清楚。由于体内FCRL4+细胞难以获取和分离,我们在此开发了一种培养系统,通过分别用可溶性CD40配体和/或CpG DNA刺激纯化的MBC,模拟T细胞依赖性和/或T细胞非依赖性激活,从而在体外产生FCRL4+B细胞。刺激4天后,FCRL4+B细胞占所有产生细胞的17%。对体外产生的FCRL4+细胞进行转录组学和表型分析表明,它们与FCRL4+扁桃体MBC密切相关。它们强烈表达抑制性受体基因,这在高病毒血症的HIV感染个体血液样本中耗尽的FCRL4+MBC中也有观察到。与此一致的是,体外产生的FCRL4+细胞中细胞周期基因显著下调,细胞分裂次数比FCRL4-细胞低两倍。最后,由于其增殖和分化潜力降低,FCRL4+细胞与FCRL4-细胞不同,不太容易分化为浆细胞。我们的体外模型对于研究正常和病理性FCRL4+细胞的生物学特性可能具有重要意义。